Title: Phase Entrainment of Induced Ventricular Fibrillation: A Human Feasibility and Proof of Concept Study.

Credits: Arun V Holden, Godon A Begg, Katrina Bounford, Berthold Stegemann, Muzahir Tayebjee

Title: Cost-effectiveness of Dabigatran exilate in treatment of atrial fibrillation

Credits: Giovanni Galvani, Alberto Grassetto, Stefania Sterlicchio, Sakis Themistoclakis, Andrea Venturini, Giampaolo Zoffoli, Domenico Mangino

Title: Mid-term risk stratification of patients with a Myocardial Infarction and Atrial Fibrillation: beyond GRACE and CHADS.

Credits: Sérgio Barra, Rui Providência, Luís Paiva, Inês Almeida, Francisca Caetano, Paulo Dinis, António Leitão Marques

Title: Performance of the Cockcroft-Gault, MDRD and CKD-EPI formulae in non-valvular atrial fibrillation: which one should be used for risk stratification?

Credits: Sérgio Barra, Rui Providência, Catarina Faustino, Luís Paiva, Andreia Fernandes, António Leitão Marques

Title: Antiarrhythmic Drug Therapy for Atrial Fibrillation: A Literature Review

Credits: Omar F Hassan, Jassim Al Suwaidi, Amar M Salam

Title: Alternative therapies in the treatment of atrial fibrillation

Credits: Federico Lombardi, MD, FESC, Sebastiano Belletti, MD, Alberto Lomuscio, MD.

Title: Rate Control for Preventing Cardiovascular Events in Atrial Fibrillation Patients

Credits: Thomas D. Callahan, MD, FACC, FHRS

Title: Demographic characteristics and patterns of medication in atrial fibrillation patients in South-West Ontario: insights from a large primary care database.

Credits: Robert J Petrella, MD, PhD, Luc Sauriol, PhD

Title: The Conversion of Paroxysmal or Initial Onset Atrial Fibrillation with Oral Ranolazine: Implications for a New "Pill-In-Pocket" Approach in Structural Heart Disease

Credits: David K. Murdock, MD, James A Reiffel, MD, Jeff Kaliebe, MT, CCRC, German Larrain, MD

Dr. Heiko Schmitt, MD, PhD.

Affiliation: Dr. Schmitt is co-director of Electrophysiology and medical director of Anti-coagulation of the Pat and Jim Calhoun Cardiology Center at UConn School of Medicine. Dr. Schmitt has clinical and research expertise on all aspects of arrhythmias diagnosis and treatment as well as device implantation. Dr. Schmitt has an active practice in clinical cardiac electrophysiology and performs electrophysiological studies and intervention at the new state-of-the-art laboratory at UConn Medical Center in Farmington, Connecticut.

Dr. John Somberg, MD.

Affiliation: John Somberg is currently a Professor of Medicine and Pharmacology at Rush University in Chicago. He also serves as Chief the Division of Clinical Pharmacology and the Director of the Masters in Clinical Research Program at Rush University. Dr. Somberg is the Editor of the American Therapeutics and has served for 14 years on the Circulatory Device Advisory Panel with the FDA. Dr. Somberg completed a cardiology fellowship at the Peter Bent Brigham Hospital, Harvard Medical School, ran the Cardiac Arrhythmia Service at Albert Einstein and was the Chief of Cardiology at the Chicago Medical School prior to his current position. His areas of specialization are anti-arrhythmic pharmacology and drug and device development.

Dr. Prashant Bhave, MD.

Affiliation: Electrophysiology Fellow at Northwestern University in Chicago. Research interests include the management and prevention of post-operative atrial fibrillation and the use of novel oral anti-coagulants.